Last reviewed · How we verify

NCT06629636

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

Recruiting now NA Last updated 8 October 2024
What this trial tests

NA trial testing NMN capsule in Repeated IVF Failure in 60 participants. Currently enrolling.

Timeline
20 August 2024
Primary endpoint
30 September 2025
31 December 2026

Quick facts

Lead sponsorSunkaky Medical Cooperation
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposebasic science
Enrollment60
Start date20 August 2024
Primary completion30 September 2025
Estimated completion31 December 2026
Sites1 location across Japan

Drugs / interventions tested

Conditions studied

Sponsor

Sunkaky Medical Cooperation

Who can join

Adults 32 to 42, female only, with Repeated IVF Failure or Female Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sunkaky Medical Cooperation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06629636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing